ModelEdge

Corporate Research Intelligence

Powerful AI-driven insights from SEC Filings, Transcripts, and Market Data

Real-time Analysis

Advanced language models process corporate data instantly

Comprehensive Data

SEC filings, transcripts, insider trades, and industry insights

Market Edge

Get the competitive advantage with data-driven decisions

Latest Market Updates

Recent press releases from leading public companies

VALE•Vale
1 day ago

Informs on Estimates Update

Outlook Update
SNY•Sanofi
1 day ago

Dupixent Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid

Other
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
SKE•Skeena Resources Ltd
1 day ago

A Copy of the News Release Dated March 31, 2026.

Other
PAM•Pampa Energy Inc
1 day ago

Reports on Foreign Issuer Form 6-K for March 2026

Other
SNY•Sanofi
1 day ago

Dupixent Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid

Other
MNSO•Miniso Group Holding Ltd
1 day ago

Reports Next Day Disclosure Returns for March 2026

Other
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
RGLD•Royal Gold Inc
1 day ago

Provides 2026 Guidance and Five Year Outlook and Announces Further Debt Repayment and Publication of Asset Handbook

Outlook Update
SITE•SiteOne Landscape Supply
1 day ago

Announces The Retirement Of Scott Salmon And The Appointment Of Daniel Laughlin As Successor

Director Change
PAM•Pampa Energy Inc
1 day ago

Successfully Places New Class 27 Notes for US$200 Million

Bonds Purchased Or Issued
VALE•Vale
1 day ago

Reports Form 6-K for March 2026

Other
SRRK•Scholar Rock Holding Corporation
1 day ago

Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

Announcement Of Date When Earnings Will Be Reported Or When It Will Be Released
UL•Unilever PLC
1 day ago

Announces Major Breakthrough in Technology

Other
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
SNY•Sanofi
1 day ago

Sarclisa Subcutaneous Formulation Administered Via On-Body Injector Recommended For EU Approval By The CHMP To Treat Multiple Myeloma

Other